[Interview with private lecturer Dr. med. Nadia Harbeck, Munich. Prognostic markers guide therapy (interview by Jochen Aumiller)]

MMW Fortschr Med. 2003 Jan 23;145(3-4):8, 10.
[Article in German]
No abstract available

Publication types

  • Interview

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Breast Neoplasms / diagnosis*
  • Breast Neoplasms / pathology
  • Breast Neoplasms / therapy
  • Female
  • Humans
  • Neoplasm Staging
  • Plasminogen Activator Inhibitor 1 / analysis*
  • Prognosis
  • Receptor, ErbB-2 / analysis*
  • Urokinase-Type Plasminogen Activator / analysis*

Substances

  • Biomarkers, Tumor
  • Plasminogen Activator Inhibitor 1
  • Receptor, ErbB-2
  • Urokinase-Type Plasminogen Activator